Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024800.5(NEK11):c.391C>T(p.Pro131Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000619 in 1,453,766 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
NEK11 (HGNC:18593): (NIMA related kinase 11) This gene encodes a member of the never in mitosis gene A family of kinases. The encoded protein localizes to the nucleoli, and may function with NEK2A in the S-phase checkpoint. The encoded protein appears to play roles in DNA replication and response to genotoxic stress. Alternatively spliced transcript variants have been described.[provided by RefSeq, Mar 2009]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.391C>T (p.P131S) alteration is located in exon 5 (coding exon 3) of the NEK11 gene. This alteration results from a C to T substitution at nucleotide position 391, causing the proline (P) at amino acid position 131 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Loss of catalytic residue at P131 (P = 0.0468);Loss of catalytic residue at P131 (P = 0.0468);Loss of catalytic residue at P131 (P = 0.0468);Loss of catalytic residue at P131 (P = 0.0468);Loss of catalytic residue at P131 (P = 0.0468);Loss of catalytic residue at P131 (P = 0.0468);Loss of catalytic residue at P131 (P = 0.0468);